Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB
|
|
- Evangeline Parsons
- 6 years ago
- Views:
Transcription
1 ADMINISTRATIVE INFORMATION Principal Investigator: Study Coordinator: Protocol Title: Current Audit Date: Research Compliance Officer (RCO) or Designated Auditor(s): Local VA VA ORD CSP Other VA ORD Sponsor and/or Support: NIH Other Federal: Other: Date of Initial IRB Approval: FDA Regs Apply: Y N Local Protocol Tracking number: Sponsor Protocol Number: or Study Acronym (if any): Drugs/Biologics: IND Req d IND not Req d Devices: NSR IDE Req d IDE not Req d IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB VA Study Site(s): (check all that apply) Local facility CBOC(s) specify Academic Affiliate Other: Study Type: (check all that apply) Single Site Trial International Study: - ORD/CRADO approval on file? Y N Multi-Center Trial Study involves children? - ORD/CRADO approval on file? Y N Study involves prisoners? - ORD/CRADO approval on file? Y N Category: (check all that apply) Biomedical Behavioral Educational Other: Current IRB Status: Actively enrolling new subjects New enrollments temporarily suspended (check all that apply) Active only for long-term observation Closed to enrollments Active only for long-term data analysis Closed / Terminated Date: For studies with intervention or interaction with living Number of subjects who Unable to determine individuals (regardless of whether identifiable private were entered into the study or number: information was obtained): since initiation: For studies ONLY obtaining identifiable private Number of subjects Unable to determine information (with no intervention or interaction with entered into the study or number: living individuals): since initiation: Research closed NO subjects entered Y N If YES, complete this page only Research closed previous HRPP regulatory audit(s) done Y N If YES, date(s) of previous HRPP audit(s), and complete this page only
2 PROTOCOL, AMENDMENTS, CONTINUING APPROVAL ETC. IRB SUBMISSIONS, APPROVALS, AND OTHER ACTIONS IRB DATES APPROVAL EXPIRATION RESEARCH & DEVELOPMENT COMMITTEE APPROVAL DATE OR N/A SUBMISSION & APPROVAL LETTERS ON FILE? / N/A Comments
3 Informed Consent Date Informed Consent Version Number VHA Triennial Regulatory Compliance Audit IRB SUBMISSIONS, APPROVALS, & OTHER ACTIONS INFORMED CONSENT DATE OF IRB APPROVAL Reason for Revision RE-CONSENT REQUIRED? IRB STAMP OR EQUIVALENT Comments
4 DATE UPR/SAE OCCURRED DATE LEARNED OF EVENT VHA Triennial Regulatory Compliance Audit LOCAL UNANTICIPATED SERIOUS ADVERSE EVENTS (SAES) UNANTICIPATED PROBLEMS INVOLVING RISKS TO SUBJECTS OR OTHERS (UPRS) SIGNIFICANT SAFETY REPORTS / DATA MONITORING COMMITTEE (DMC) REPORTS SUBJECT ID EVENT DATE REPORTED TO IRB REPORTED TO IRB WITHIN REQUIRED TIME PERIOD REVIEWED & CATEGORIZED WITHIN REQUIRED TIME PERIOD CATEGORIZED BY IRB U R S REPORTED TO ORO U Unanticipated R Related to study participation S Serious
5 STUDY STAFF QUALIFICATIONS AND TRAINING i SITE PERSONNEL HSP/GCP TRAINING COI INFORMATION SECURITY 201 DELEGATION OF AUTHORITY SIGNATURES CV/ RESUME WOC SAFETY TRAINING INITIAL TRAINING NOT COMPLETED PRIOR TO RESEARCH SCOPE OF PRACTICE OR EQUIVALENT DOCUMENTED Role in Study PI/SC FDA Form 1572 P.I.
6 SUBJECT STUDY ID VHA Triennial Regulatory Compliance Audit SUBJECT RECORD REVIEW ASSESS TIMING OF CONSENT, COMPLIANCE WITH ELIGIBILITY CRITERIA, ETC. TOTAL NUMBER OF SUBJECTS WHO PASSED SCREENING AND WERE INCLUDED FOR ANALYSIS IN STUDY IN THIS PERIOD = IF FEWER THAN 10 SUBJECTS IN THIS PERIOD, AUDIT ALL OF THEM IF SUBJECTS IN THIS PERIOD, AUDIT 10 OF THEM IF SUBJECTS IN THIS PERIOD, AUDIT 10% OF THEM IF MORE THAN 300 IN THIS PERIOD, AUDIT 30 OF THEM DOCUMENTATION THAT CONSENT OBTAINED PRIOR TO INITIATION OF STUDY PROCEDURES DOCUMENTATION FOUND VERIFYING INCLUSION CRITERIA MET DOCUMENTATION FOUND VERIFYING EXCLUSION CRITERIA NOT MET Subject Included in Research in presence of documentation that inc/excl criteria were not met Other issues found, specify on line below
7 IRB rules for reporting protocol deviations/violations to IRB: VHA Triennial Regulatory Compliance Audit PROTOCOL DEVIATIONS / VIOLATIONS Deviations, if any, reported to IRB per IRB rules: Yes No Deviations, if any, recorded in compliance with protocol requirements: Yes No NA Drug Device INVESTIGATIONAL PRODUCT ACCOUNTABILITY IN INVESTIGATOR REGULATORY BINDER Product accountability records (storage, inventory, dispensing) maintained? Yes No NA Comments: VAF (Summary Drug Information) on file in the Site regulatory file? Yes No NAComments: Investigator Brochure or Package Insert on File? Yes No NA Comments: Custody & Storage of investigational product (drug and/or device): N/A Pharmacy Investigator Other Complies with the facility requirements or as stipulated by the IRB/R&D Committee? Yes No Comment: OTHER COMMENTS If there anything the RCO/auditor thinks should be noted about this audit, please note/comment here:
8 Document Investigator Regulatory Files Protocol & Amendments Present and Reviewed Comments AUDIT PREPARATION TOOL Document Investigator Regulatory Files R&D Correspondence Present and Reviewed Comments Approved Case Report Forms Notes-to-File IRB Approved Consent Forms -Information Provided to Subjects -HIPAA Forms -Advertisements -Record of Approved Consent Form Versions Site-Sponsor Correspondence, if app. -Conference call minutes - s -Newsletters -Conference calls -Letters, memos, faxes Subject Log (current/accurate) Study Site Personnel Signatures, Qualifications, Training, Scope of Practice, CVs, Delegation IRB Correspondence Signed Attestation or Investigator s Agreement (Sponsor, Institution, FDA) IRB Submissions, Notifications, Approvals Official Documents Letters, Memos, etc. Serious Adverse Events/Safety Reports Signed PI Conflict of Interest/Disclosure Statement Investigator Brochure/VA Form Investigational Products, if applicable Accountability, Handling, Pharmacy, Elsewhere - Are there local IRB requirements for record keeping? Yes No NA Comments:
9
Self-Monitoring Tool
This form is designed for research personnel to use to assess their compliance with TTUHSC El Paso IRB policies and procedures, and federal regulations and guidance governing research with human subjects,
More informationHIC Standard Operating Procedure. For-Cause Audits of Human Research Studies
HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,
More informationCLOSE OUT VISIT REPORT (NO CRF TO MONITOR)
Date: Page: 1 of 8 CLOSE OUT VISIT REPORT (NO CRF TO MONITOR) Protocol: PI Name: PI Address: Date of Visit: Monitor(s): Other Sponsor Personnel Present: Site Personnel Present at Visit (include names and
More information12.0 Investigator Responsibilities
12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement, the investigational
More informationRegulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies
Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies DIRECTIONS: 1. The purpose of a regulatory binder is to assure that all essential elements are maintained in an organized
More informationQUALITY ASSURANCE PROGRAM
QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support
More informationRecord or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;
TEXAS HEALTH RESOUCES Table 17-III. Record Retention Schedule Human Subject Research Records and Documents Approved by THR System Performance Council (SPC): 19 January 2010 Effective Date: October 14,
More informationFAQs March 12, 2012 FREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS Table of Contents (Click to follow links) The National Cancer Institute s Central IRB (NCI CIRB)... 2 Standalone HIPAA Authorizations... 3 Retroactive CRADO Waivers... 4 Implementation
More informationVCU Clinical Research Quality Assurance Assessment
VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment
More informationBIMO SITE AUDIT CHECKLIST
Item AUTHORITY AND ADMINISTRATION FOR STUDIES INVOLVING HUMAN DRUGS, BIOLOGICS AND DEVICES 1. Compare the Investigator Agreement with the information provided by the assigning Center. Auditor will check
More informationSARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY TITLE: Satellite Site Management Plan Job Title of Reviewer: POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY TYPE: Elizabeth Carr, R.N.,
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationWIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)
WIRBinar How to Survive an FDA Inspection 10-26-2011 Brought to you by WIRB Education and Consulting Services. Improve your ability to maintain compliance and protect human subjects with guidance from
More informationSTUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)
POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both
More informationTufts Medical Center (Tufts MC) and Tufts University Health Sciences (TUHS) IRB Western IRB (WIRB) Submission Policy
Tufts Medical Center (Tufts MC) and Tufts University Health Sciences (TUHS) IRB Western IRB (WIRB) Submission Policy Policy/Procedure Phase II (IIa, IIb, or II), III, or IV protocols undertaken at Tufts
More informationRequest to Use an External IRB as an IRB of Record
This form is to be used by investigators requesting use of an external IRB. Please submit this completed form, along with the required attachments, to the MHC IRB at hrpp@mclaren.org. (Please see SOP:
More informationEffective Date: 11/09 Policy Chronicle:
Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:
More informationLOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)
LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP) Effective Date: February 7, 2013 SOP Title: Study Monitoring Visits - Process for Access
More informationUniversity of South Carolina. Unanticipated Problems and Adverse Events Guidelines
University of South Carolina Unanticipated Problems and Adverse Events Guidelines These guidelines define the procedures of USC for addressing unanticipated problems involving risks to research participants
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationMastering Clinical Research April 19, :30 am
Mastering Clinical Research April 19, 2017 7:30 am New Question and Answer Response System Log In Directions Use the following link to access pre and post test questions: http://www.socrative.com/ Click
More informationDepartment of Defense Human Research Protection Program DOD INSTITUTIONAL AGREEMENT FOR INSTITUTIONAL REVIEW BOARD (IRB) REVIEW (IAIR)
Department of Defense Human Research Protection Program DOD INSTITUTIONAL AGREEMENT FOR INSTITUTIONAL REVIEW BOARD (IRB) REVIEW (IAIR) General Instructions to Institutions and IRBs This form should be
More informationDANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:
POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.
More informationDocumenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC
Documenting the Story of a Clinical Trial: Concept to CAPA Lori T. Gilmartin Gilmartin Consulting LLC The regulations represent the floor while ethical thinking is the sky. Dr. Thomas Moore Boston University
More informationInitially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees
Location: Los Angeles Research Institute: Los Angeles, CA Investigation Product/Test Article: Laftr Visit Mechanism: On-site Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009
More informationNational Cancer Institute. Central Institutional Review Board. Standard Operating Procedures
National Cancer Institute Central Institutional Review Board Standard Operating Procedures CIRB Standard Operating Procedures Additional copies are available from the CIRB website (http://www.ncicirb.org)
More informationLoyola University Chicago Health Sciences Division Maywood, IL. Human Subject Research Project Start-Up Guide
Loyola University Chicago Health Sciences Division Maywood, IL Human Subject Research Project Start-Up Guide This Start-Up Guide is intended to guide you through the process of designing a research project
More informationTITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18
SOP #: RCO-204 Page: 1 of 5 1. POLICY STATEMENT: The research team is responsible for recognizing changes in subject health that may qualify as adverse events, classifying those results as defined in the
More informationEssential Documents It s Not Just a Binder!
Essential Documents It s Not Just a Binder! Kelly Unsworth, MS, CCRC, CIP Director of Research Education & Training Office for Human Subject Protection SCORE June 5, 2014 But What percentage of 2014 (to
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationUniversity of Colorado Denver Human Research Protection Program Investigator Responsibilities for the Protection of Human Subjects
Institutional Guidelines The Colorado Multiple Institutional Review Board (COMIRB) recently reviewed and approved your research. The COMIRB reviews research to ensure that the federal regulations for protecting
More informationFDA Medical Device Regulations vs. ISO 14155
Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50
More informationMARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-D
Page 1 of 8 MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: Title: Data Safety and Monitoring Committee Administrative and Revision: N/A Revision Date: N/A Functional
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationUniversity of Illinois at Chicago Human Subjects Protection Program Plan
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 University of Illinois at Chicago Human Subjects Protection Program Plan 203 AOB (MC 672) 1737 West Polk Street
More informationPROMPTLY REPORTABLE EVENTS
PROMPTLY REPORTABLE EVENTS PURPOSE AND SCOPE To define the structure and responsibility for reporting unanticipated problems that occurs during the conduct of research. APPLICABLE REGULATIONS Policy II.02
More informationClinical Trial Quality Assurance Common Findings
Clinical Trial Quality Assurance Common Findings Objectives Identify common findings found in research study reviews conducted by the CTQA Program Understand what findings require an action plan vs. a
More informationEffective Date: November 12, 2015 Policy Number: MHC_RP0306. Corporate Director, HRPP Institutional Official, HRPP
Policy Title: Education and Training In Human Subject Research Effective Date: November 12, 2015 Policy Number: Review Date: November 12, 2015 Section: Revised Date: Administrative Responsibility: Oversight
More informationETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM
ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM Outline Introduction Composition Responsibilities of IEC Responsibilities
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationOffice of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators
Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,
More informationRoles & Responsibilities of Investigator & IRB
Roles & Responsibilities of Investigator & IRB Jaranit Kaewkungwal Mahidol University Regulatory & Guidelines Regulatory & Guidelines GCP & Computer / Database Management Systems International Conference
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationUniversity of California, San Diego Human Research Protections Program Institutional Review Board Standard Operating Policies and Procedures
University of California, San Diego Human Research Protections Program Institutional Review Board Standard Operating Policies and Procedures Version date: 5/28/2004 Table of Contents Section One: General
More informationHuman Research Protection Program Institutional Review Board
Human Research Protection Program Institutional Review Board Policies and Procedures Guidebook TABLE OF CONTENTS Federal, State and University Regulations Related to the IRB... Section 1.0 Definition of
More informationBiomedical IRB MS #
Department for Human Research Protections Institutional Review Boards Biomedical IRB MS # 1035 419-383-6796 IRB.Biomed@utoledo.edu Social, Behavioral and Educational IRB MS # 944 419-530-6167 IRB.SBE@utoledo.edu
More informationDr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationGood Documentation Practices. Human Subject Research. for
Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated
More informationStudy Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting
Study Management SM 306.00 STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick M. Schnell, MD,
More informationPreparing for Audits and Post Approval Monitoring April 29, 2015
Preparing for Audits and Post Approval Monitoring April 29, 2015 Presented By: Piper Hawkins Green, CIP Olga Jonas, CIP IRB Compliance Analyst IRB Compliance Analyst Presentation Agenda Regulatory background
More informationSuccessful FDA Inspections at Investigative Sites for Clinical Trials of Drugs and Biologics
Vol. 9, No. 1, January 2013 Happy Trials to You Successful FDA Inspections at Investigative Sites for Clinical Trials of Drugs and Biologics By Swati Tendolkar The United States Food and Drug Administration
More informationRESEARCH SUBJECTS PROTECTION DIVISION
NAVAL MEDICAL CENTER PORTSMOUTH RESEARCH SUBJECTS PROTECTION DIVISION Guidebook for Extramural IRB Submissions Kersten Wheeler, MS Elizabeth Dayag, CIP, CCRP Melvina Queen, CIP, CCRP Research Subjects
More informationThe Greenville Hospital System Office of Research Compliance and Administration HRPP Policies and Procedures
The Greenville Hospital System Office of Research Compliance and Administration HRPP Policies and Procedures Title: Western Institutional Review Board (WIRB) HRPP Policy No. 33.02 Effective Date: May 2012
More informationWhen a Single IRB Reviews for Multiple Sites:
When a Single IRB Reviews for Multiple Sites: The Complexities of Simplification John Ennever, MD, PhD Director Office of Human Research Affairs Boston Medical Center and Boston University Medical Campus
More informationFDA Inspection Readiness
FDA Inspection Readiness Richard Angelo, Ph.D. Director, Managing Consultant October 17, 2014 Agenda Reasons for Inspections Preparing for Inspections Inspection Day Inspection Outcomes 2013 Inspection
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationStudy Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)
Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationA Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators
More informationSTUDY TEAM RESPONSIBILITIES ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2
ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2 Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals Overall Agenda for Orientation Module 1: Introduction
More informationGenesis Health System. Institutional Review Board. Standard Operating Procedures
Genesis Health System Institutional Review Board Table of Contents 1. INSTITUTIONAL AUTHORITY... 6 2. PURPOSE... 6 3. THE SCOPE & AUTHORITY OF THE IRB... 7 Scope...7 Authority of the GHS-IRB...7 Authority
More informationFrequently Asked Questions. The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore
1. Where is the location of the CIRB? The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore 150168. 2. When is the submission deadline? The CIRB meets once a month. The submission
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More information10 STEPS TO IRB APPROVAL
10 STEPS TO IRB APPROVAL STEP 1: OBTAIN CITI TRAINING CERTIFICATE ALL STUDY PERSONNEL MUST TAKE AN ONLINE HUMAN SUBJECTS TRAINING EDUCATION PROGRAM. THE CERTIFICATES OF COMPLETION ARE NEEDED FOR ALL STUDY
More informationOffice of Human Research Office of Human Research Policy and Procedure Manual. Version: 4/4/18
Version: 4/4/18 Signatures on File for the Approval of Revisions to the Policy and Procedures Table of Contents 100 General Administration (GA)... 5 Policy GA 101: The Authority and Purpose of the Institutional
More informationUSING SMART IRB AND SINGLE IRB REVIEW
USING SMART IRB AND SINGLE IRB REVIEW Jeannie Barone Director, HRPO ATTRIBUTES Special thanks to Nichelle Cobb, PhD from University of Wisconsin-Madison for her permission to utilize her slides on SMART
More informationClinical Trial Readiness Checklist October 2014
The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the
More informationThe Alfred Streamlining Ethical Review Guide. Overview Page 1. The Review Schemes - A description the two different schemes Page 2
The Alfred Streamlining Ethical Review Guide This Guide contains: Overview Page 1 The Review Schemes - A description the two different schemes Page 2 What is meant by Reviewing or Accepting? Page 2 Where
More informationI. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.
Human Research Protection Program Policies & Procedures Unanticipated Problems and Adverse Events Version 3.0 Date Effective: 11.9.2012 Research Integrity Office Mail code L106-RI Portland, Oregon 97239-3098
More information11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4
UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities BEVERLY ALGER, CCRP, CHRC Research Compliance Officer Office of Research Compliance November 2016
More informationUNIVERSITY MEDICAL CENTER NEW ORLEANS RESEARCH REVIEW APPLICATION
UNIVERSITY MEDICAL CENTER NEW ORLEANS RESEARCH REVIEW APPLICATION Submission and Approval Process 1. Submit complete RRC application to Office of Research as early as possible in study process. 2. Quality
More informationTitle: Investigator Responsibilities. SOP Number: 1501 Effective Date: June 2, 2017
Previous Version Dates: Title: Investigator Responsibilities SOP Number: 1501 Effective Date: June 2, 2017 1 Purpose Investigators are ultimately responsible for the conduct of research. Investigators
More informationUtilizing the NCI CIRB
Policy P15 Written By: B. Laurel Elder, Ph.D. Created: September 2, 2011 Edited Version P15.1 Utilizing the NCI CIRB PURPOSE - The purpose of this Standard Operating Procedure (SOP) is to outline the procedures
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationSetting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016
Setting up a CITI account for users not enrolled at or employed by Georgia Tech Georgia Institute of Technology December 2016 www.citiprogam.org Select REGISTER to establish an account. Affiliate with
More informationPresented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals
ORIENTATION FOR NEW CLINICAL RESEARCH COORDINATORS Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals Overall Agenda for Orientation Module 1:
More informationInvestigator Training Program March 9, The Mechanics of Performing a Clinical Trial. Michelle Cavallerano, CCRP Mary Lou Watson, BA, RRT, CCRP
Investigator Training Program March 9, 2010 The Mechanics of Performing a Clinical Trial Michelle Cavallerano, CCRP Mary Lou Watson, BA, RRT, CCRP In Summary. Clinical trials are partnerships between sponsor,
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationUT Southwestern Medical Center Human Research Protection Program Policy, Procedure and Guidance Documents
UT Southwestern Medical Center Human Research Protection Program Policy, Procedure and Guidance Documents Updated July 1, 2018 Page 2 of 342 Table of Contents 1. HRPP Office Review 1.1. RECEIVING, ROUTING,
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationINSPIRing Changes to the IRB Process: New templates and more
INSPIRing Changes to the IRB Process: New templates and more John F. Ennever, MD, PhD, CIP Director, Human Research Protection Program Office of Human Research Affairs Boston Medical Center and Boston
More informationEMA Inspection Site perspective
EMA Inspection Site perspective Hermien Gous Wits RHI Shandukani Research Centre 27.09.2016 Cape Town Why were we inspected times? Pharmaceutical company applied for registration of the study drug in a
More informationFDA Inspectional Process in Clinical Research An FDA Perspective. Annette Melendez, MPHsN Investigator Office of Biological Products Operations
FDA Inspectional Process in Clinical Research An FDA Perspective Annette Melendez, MPHsN Investigator Office of Biological Products Operations Outline BIMO PROGRAM OVERVIEW PROGRAM COVERED AREAS INSPECTIONAL
More informationNN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION
NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:
More informationBUSINESS RELATIONSHIPS BETWEEN STAFF AND PHARMACEUTICAL COMPANY REPRESENTATIVES
Department of Veterans Affairs MEMORANDUM NO. 119-11 North Florida/South Georgia Veterans Health System Change 5 March 15, 2013 BUSINESS RELATIONSHIPS BETWEEN STAFF AND PHARMACEUTICAL COMPANY REPRESENTATIVES
More informationPresented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals
ORIENTATION FOR NEW CLINICAL RESEARCH COORDINATORS Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals Overall Agenda for Orientation Module 1: Introduction
More informationThe Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.
The Clinical Research Center Research Practice Manual Guideline for Study Document and Data Handling RPG-08 Purpose Guideline This Guideline provides functional definitions for common data management terms;
More informationInvestigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser
Investigator-Initiated Studies: When you re the Sponsor Cheri Robert & Tammy Mah-Fraser ACRC Clinical Research Conference Edmonton, AB October 15, 2014 Session Objectives Define roles of the investigator,
More informationHuman Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance
Human Subjects Research Policy Update Naomi Coll Director of Research Policy and Compliance Major Policy Updates 1. Continuing review (annual renewal) is no longer required for minimal risk research 2.
More informationGuide to Completing Medical University of South Carolina s Institutional Review Board (IRB) Continuing Review Application
Guide to Completing Medical University of South Carolina s Institutional Review Board (IRB) Continuing Review Application This guide has been developed to help researchers complete IRB continuing review
More informationeirb Review Checklist
Start an eirb On-Line Submission Analysis Form Section Review Details Section 1: Study Identification & Personnel Study Identification Look for spelling in both Full and Short title. Make sure dates match
More informationHonorHealth Research Institute. Investigator Manual. July 27, Version 3.0
HonorHealth Research Institute Investigator Manual July 27, 2017 Version 3.0 VERSION 3.0 JULY 27, 2017 1 Table of Contents Scope... 5 Version History... 5 What is the purpose of this manual?... 5 Abbreviations...
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More informationStudy Monitoring Plan Template
Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &
More informationIRB 101. Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix
IRB 101 Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix Contents Brief discussion of regulations IRB Structure Levels of Approval Informed Consent HIPAA/HITECH
More information